what is the mechanism of action of glp 1 agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Resmetirom and GLP-1 agonists for

Under glucose-deprived conditions, the knockout of IDH1 or ME1 significantly reduces the NADPH/NADP+ and GSH/oxidized GSH ratios, leading to elevated ROS levels and increased cell death in cancer cells (94)

According to the latest EASL Clinical Practice Guidelines, non-invasive scores, serum markers, liver stiffness and imaging methods should be used for ruling out rather than diagnosing advanced fibrosis in low-prevalence populations and should be preferentially employed in patients at risk of advanced liver fibrosis (63)

Its main job is to act as a cellular bodyguard

Unlike synthetic signal peptides, GHK itself is endogenous, meaning the body already recognizes it as part of its repair cascade

10.1016/S0140-6736(18)32348-1

that is, not all cancer cells exhibit an increase in ROS or NAD + depletion upon NAMPT inhibition